3,4-Methylenedioxymethamphetamine (MDMA) increases sociality in humans and animals. Release of serotonin (5-HT) is thought to have an important role in the increase in social behaviors, but the mechanisms underlying these effects are poorly understood. Despite the advantages of nonhuman primate models, no studies have examined the mechanisms of the social effects of MDMA in nonhuman primates. The behavior and vocalizations of four group-housed squirrel monkeys were examined following administration of MDMA, its enantiomers, and methamphetamine. 5-HT receptor antagonists and agonists were given as drug pretreatments. Data were analyzed using linear mixed-effects models. MDMA and its enantiomers increased affiliative social behaviors and vocalizations, whereas methamphetamine had only modest effects on affiliative behaviors. Pretreatment with a 5-HT 2A receptor antagonist and a 5-HT 2C receptor agonist attenuated the MDMA-induced increase in social behaviors, while a 5-HT 1A receptor antagonist did not alter affiliative vocalizations and increased MDMA-induced social contact. Nonhuman primates show MDMA-specific increases in affiliative social behaviors following MDMA administration, in concordance with human and rodent studies. MDMA-induced increases in social behaviors are 5-HT 2A , but not 5-HT 1A , receptor dependent. Understanding the neurochemical mechanisms mediating the prosocial effects of MDMA could help in the development of novel therapeutics with the unique social effects of MDMA but fewer of its limitations.
INTRODUCTION
The amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA) is the essential active component of the club drug 'ecstasy,' and increased sociability is cited as a main reason for its recreational usage (Sumnall et al, 2006) . MDMA increases social interaction, self-reported ratings of social feelings, and the number of social words used in humans, as well as increasing adjacent lying (a passive social interaction) and social conditioned place preference in rodents (see Kamilar-Britt and Bedi, 2015) .
Behaviorally active doses of racemic MDMA release monoamines into the synapse (Rietjens et al, 2012) . Recreationally and clinically used MDMA is usually a 1 : 1 mixture of enantiomers, although stereoselective disposition increases the ratio of R(− ) MDMA overtime (Fallon et al, 1999) . The stereoisomers have different pharmacological profiles; S(+) MDMA increases dopamine and serotonin (5-HT), while R( − ) MDMA less potently releases 5-HT but has little effect on dopamine release (Murnane et al, 2010) . Additionally, R( − ) MDMA binds to specific receptors (eg, 5-HT 2 ) (Lyon et al, 1986) . The potency for 5-HT release is greater than other psychostimulants (Rothman et al, 2001) , which is thought to mediate the unique subjective profile of racemic MDMA (Liechti et al, 2000a) . However, additional mechanisms underlying the prosocial effects of MDMA are not well understood.
Rodent studies indicate that activation of the 5-HT 1A receptor may be necessary for MDMA-induced adjacent lying (eg, Thompson et al, 2007) . However, human studies using pindolol, a beta-adrenergic antagonist that also partially blocks 5-HT 1A receptors, found that 5-HT 1A receptors were not necessary for MDMA-induced social feelings or changes in emotional empathy (van Wel et al, 2012; Kuypers et al, 2014) .
Another important 5-HT receptor that could have a role in the unique social effects of MDMA is the 5-HT 2A receptor. Several of the effects of MDMA are 5-HT 2A receptor dependent, including hyperlocomotion (Herin et al, 2005) , changes in body temperature (Herin et al, 2005) , and striatal dopamine overflow (Schmidt et al, 1994) . Some human literature supports the role of the 5-HT 2A receptor in the social effects of MDMA. Ketanserin, a 5-HT 2A/2C antagonist, blocked MDMA-induced positive affect (van Wel et al, 2012) and emotional excitation but did not decrease the ratings of extroversion or positive mood (Liechti et al, 2000b) . The mixed 5-HT 2A/2C profile of ketanserin might contribute to the conflicting results, given that 5-HT 2A and 5-HT 2C receptors often have opposing effects on psychostimulantinduced behaviors and dopamine overflow in the striatum (Howell and Cunningham, 2015) .
The present study evaluated the social effects of MDMA, its enantiomers, and methamphetamine in squirrel monkeys. Methamphetamine was used to examine the social effects of a similar amphetamine-derivative but with a higher dopamine to 5-HT release profile (Rothman et al, 2001 ). Additionally, this study examined the receptor pharmacology underlying MDMA-induced social behaviors. Animal experiments allow for the use of novel, and more selective, antagonists to better understand the pharmacological mechanism of the social effects of MDMA. Further, squirrel monkeys have a pharmacokinetic profile for MDMA similar to humans (Mueller et al, 2009) , providing considerable translational relevance, given the concern that different pharmacokinetic processing can alter the effects of MDMA (Green et al, 2012) . Despite these advantages, only one study has examined the social effects of MDMA in nonhuman primates (Ballesta et al, 2016) , and no studies have used nonhuman primates to analyze the mechanisms underlying the social effects of MDMA. Here behavioral and vocal changes were examined following administration of MDMA, its enantiomers, or methamphetamine. Additionally, receptor-specific antagonists were used to investigate the role of the 5-HT 2A and 5-HT 1A receptors in the social effects of MDMA.
MATERIALS AND METHODS

Subjects
Four adult male squirrel monkeys (Saimiri boliviensis) weighing between 800 and 1300 g and between 11 and 16 years of age were used in all studies. Subjects were group housed in a 1.4 ×1.8 × 0.7 m 3 cage with access to swings and perches. The colony and laboratory were kept at~23°C. Subjects were fed twice daily (monkey chow: Harlan Teklad, Madison, WI; fresh fruits and vegetables), had ad libitum access to water, and received daily enrichment (ie, foraging opportunities and different toys that were changed daily). All subjects had previous exposure to drugs acting on monoaminergic and/or glutamatergic systems (eg, Cooper et al, 2014) . However, the last drug exposure for all animals was at least 2 years before the beginning of this study. All studies were conducted in accordance with the National Institute of Health's Guide for the Care and Use of Laboratory Animals, the Association for Accreditation of Laboratory Animals Care, and were approved by the Institutional Animal Care and Use Committee of Emory University.
Experimental Protocol
For experimental sessions, the home cage was moved to a laboratory room separated from the colony. Subjects were left alone in the laboratory for 2 h before drug administration to habituate to the environment. All subjects were given the same dose of racemic MDMA (0.03-1.0 mg/kg, i.m.), S(+) or R(− ) MDMA (0.3-3.0 mg/kg, i.m.), methamphetamine (0.01-0.3 mg/kg, i.m.), or sterile saline. Doses of drugs were given in a randomized order with at least 2 days in between drug administrations. Pretreatments with M100907 (M100) (0.1 and 0.3 mg/kg, i.m.), a selective 5-HT 2A receptor antagonist (Table 1) , were administered 1 h prior to MDMA administration. Pretreatments with WAY163909 (WAY163) (0.03 and 0.3 mg/kg, i.m.), a selective 5-HT 2c receptor agonist (Table 1) , were administered 45 min prior to MDMA administration. These doses and time frames were chosen because they have been shown previously to affect behavior, neuroendocrine response, and neurotransmitter release following stimulant administration (eg, Fantegrossi et al, 2009) . Pretreatments with WAY100635 (WAY100) (0.1 and 0.3 mg/kg, i.m.), a selective 5-HT 1A receptor antagonist (Table 1) , were administered 20 min prior to MDMA administration. Dose and timing were based on previous studies in marmosets (Harder and Ridley, 2000) and rodents (Thompson et al, 2007) . Saline (sterile 0.9%, i.m.) controls were performed in between drug administration days. Experiments were broken into two testing phases, with baselines collected at the beginning of the experiment and before WAY163 and WAY100 testing. For 1 h following drug administration, subjects were videotaped (Samsung F90BN HD camcorder, Suwon, South Korea) and vocalizations were recorded (Seinheiser K6 microphone (Wedemark, Germany) on a Focusrite Scarlett 2i audio interface (High Wycombe, UK) using the Ableton live lite 8 software (Berlin, Germany).
For behavioral outcomes, a reviewer blinded to drug condition watched the video recordings and used a Baldwin and Baldwin, 1981) . The ethogram also included duration of activity, aggression (eg, chasing and head grasping), and residual (ie, not performing other scored behaviors) (Hopf et al, 1974) . The focal animal scoring technique (Altmann, 1974) was used to assess duration of behaviors. Each monkey was assessed for 5 min within each of three, 20-min blocks across the hourlong observation period (ie, each monkey was scored for 15 total minutes across the hour). The order of scoring was randomized across trials but kept consistent across the three blocks within a single hour session. Auditory files of vocalizations for the entire group were converted to spectrogram files in the MATLAB software (The MathWorks, Natick, MA) using software customwritten by Sober and Brainard (2009) . Vocalizations were distinguished based on shape of spectrogram and classified into one of the three categories. Vocalizations categorized as affiliative were chucks, purrs, and pulsed calls. These call types are associated with huddling, soliciting contact from a partner, or providing important information to the troop, respectively (Jurgens, 1979; Smith et al, 1982) . The other two vocalizations were growls, calls commonly observed in connection with threat displays and aggression, and peeps, observed during exploration and after changes in the environment (Winter, 1968; Jurgens, 1979) . [6,7,1hi] indole) was a generous gift from Pfizer Incorporated (New York, NY) and was dissolved in a 10 mg/ml solution of beta cyclodextrin. Doses were calculated from salt weights.
Data Analysis
The behavioral and vocalization data were analyzed using linear mixed-effects models (LMMs) following log(y+1)-transformation of the dependent variables. This method reliably controls type I error rates and is more parsimonious than generalized linear mixed-effects models (GLMMs) that are often applied to non-Gaussian data when testing for significance of regression coefficients (Warton et al, 2016) . We conducted all statistical analyses in R statistical software (R Core Team, 2014) , and LMMs were computed using the lme4 package (Bates et al, 2012) . To evaluate the possibility that more complex GLMMs better describe the relationships between dose, behavior, and vocalizations, we also implemented GLMMs with a log-link function (ie, Poisson regression) and compared pseudo-R-squared values between the GLMM and corresponding LMM using the MuMIn package (Barton, 2015) . GLMM results did not qualitatively differ from the linear model results and are therefore reported in Supplementary Table S1 instead of the main text.
Behavioral data was modeled in seconds and included dose and bin (within the 1 h observation period) as fixed effects and controlled for random effects of study subject and testing day. Vocalization data (group-wide frequency) were summed into 6, 10-min bins across the 1 h observation period and were modeled as frequencies (ie, counts), with dose and bin as fixed effects and the random effect of testing day.
As dose-response curves are sometimes non-linear, we also tested for polynomial relationships between drug dosage and behavioral and vocalization responses by re-running each LMM with an orthogonal, second-order polynomial (ie, quadratic) dosage term as a fixed effect. We tested for improvements in fit over the simpler monomial linear models using chi-squared statistics implemented in lme4. When results of the likelihood-ratio test suggested an improved fit for the polynomial models, we tested for significance of the fixed effects and report regression coefficients and t-statistics from the polynomial models (Supplementary Table S1 ).
Model residuals were visually inspected for homoscedasticity, and normality was assessed using the one-sample Komlogorov-Smirnov test to examine deviation of standardized residuals from a theoretical standard normal distribution. Model degrees of freedom (df), t-statistics, and p-values for fixed effects in LMMs were obtained by using residual maximum likelihood tests with Satterthwaite approximations of df using the lmerTest package (Kuznetsova et al, 2015) .
RESULTS
MDMA and its Enantiomers Increase Affiliative Social Behaviors
To examine whether MDMA increased affiliative behaviors in nonhuman primates, huddling and activity were scored for 1 h following drug administration. No aggressive interactions were observed during testing and stereotypies were not quantified, but no adverse effects were seen. MDMA increased huddling (β dose = 18.5, t 330 = 9.98, po0.001; Figure 1a , Supplementary Figure S1A ) and decreased activity (β dose = −15.3, t 330 = − 9.32, po0.001) (Figure 1b) . Both enantiomers of MDMA also significantly increased huddling (β dose = 24.9, t 29 = 8.40, po0.001) and decreased activity (β dose = − 0.96, t 27 = − 7.40, po0.001). At lower doses, S(+) MDMA increased huddling (β drug × dose = − 55.5, p = t 125 = − 4.23, po0.001) and reduced activity levels (β drug × dose = − 1.25, t 125 = − 4.23, po0.001) relative to R(− ) MDMA (Figure 1c -f, Supplementary Figure  S1B and C). In contrast to racemic MDMA and its enantiomers, methamphetamine did not significantly increase huddling or change activity levels (Figure 1g and h, Supplementary Figure S1D ; Supplementary Table S1 ).
MDMA and its Enantiomers Increase Affiliative Vocalizations
MDMA increased the number of affiliative vocalizations in the hour following drug administration (β dose = 7.79, t 19 = 4.77, po0.001) (Figure 2a ). All three types of affiliative vocalizations increased following MDMA administration, with pulsed calls increasing the most from baseline (~5000%). Purrs also increased from baseline (~1500%) but represent lower total numbers than pulsed calls and chucks (Figure 2b ). Both the R(− ) and S(+) enantiomers of MDMA also significantly increased affiliative calls (β dose = 11.4, t 19 = 8.28 po0.001), though the R( − ) enantiomer was associated with more affiliative calls at higher doses compared with the S(+) enantiomer (β drug × dose = −27.2, t 19 = − 5.99, po0.001) (Figure 2c  and d) . In contrast, methamphetamine was not associated with increased affiliative vocalizations (Figure 2e ; Supplementary Table S1 ). 
MDMA and its Enantiomers Affect Other Vocalizations
Changes to two other main categories of vocalizations, peeps and growls, were also examined following drug administration. MDMA decreased peep call frequency (β dose = − 6.47, t 20 = − 5.12, po0.001; Figure 3a ) and increased growl frequency (β dose = 5.11, t 20 = 9.85, po0.001; Figure 3b ) during the session. Again, both the R(− ) and S(+) enantiomers of MDMA decreased peep calls (β dose = −0.46, t 21 = − 2.61, p = 0.016) (Figure 3c and e) and increased growls (β dose = 7.24, t 143 = 9.58, po0.001) (Figure 3d and f) . In comparing the potency and efficacy of the two stereoisomers, S(+) MDMA had stronger effects on peep calls than R(− ) MDMA as dosage increased (β drug × dose = −0.88, t 21 = − 2.73, p = 0.012), whereas the R(− ) enantiomer had stronger effects on growls at higher doses (β drug × dose = −12.9, t 143 = − 5.15, po0.001). Methamphetamine also significantly decreased peep call frequency (β dose = − 6.96, t 17 = − 4.20, po0.001; Figure 3g ) but did not change the frequency of growls emitted (Figure 3h ; Supplementary Table S1 ).
MDMA-Induced Affiliative Behaviors are 5-HT 2A , but not 5-HT 1A , Dependent
To examine the receptor pharmacology underlying the effects of MDMA on nonhuman primate behaviors and vocalizations, we administered 5-HT receptor antagonists or agonists prior to MDMA administration. M100, a selective 5-HT 2A receptor antagonist, blocked MDMA-induced huddling (β MDMA × M100 = − 23.8, t 17 = − 4.20, po0.001) (Figure 4a ). M100 trended (po0.1) toward reducing MDMA-induced affiliative calls (β MDMA × M100 = − 12.3, t 23 = − 1.90, p = 0.071) and including the interaction in the model significantly improved model fit (Figure 4b ). M100 did not significantly attenuate MDMA-induced decreases in activity levels (Supplementary Figure S2A) .
Administration of WAY163, a selective 5-HT 2C agonist, also significantly attenuated MDMA-induced huddling (β WAY163 × MDMA = − 14.7, t 190 = − 2.11, p = 0.036; Figure 4c ) but had no effect on affiliative calls following MDMA administration (Figure 4d ; Supplementary Table S2 ). WAY163 had no significant effect on MDMA-induced decreases in activity (Supplementary Figure S2B) . WAY100, a selective 5-HT 1A receptor antagonist, augmented huddling following MDMA administration (β WAY100 × MDMA = 14.9, t 184 = 2.34, p = 0.020; Figure 4e ) but did not modify MDMA-induced affiliative calls (Figure 4f ; Supplementary Table S2) . Similar to MDMA, WAY100 administration decreased activity (β WAY100 = − 4.74, t 184 = − 3.80, po0.001; Supplementary Figure S2C ) but did not moderate the effects of MDMA on activity.
Together, these findings suggest that MDMA-induced affiliative behaviors are 5-HT 2A receptor, but not 5-HT 1A , receptor dependent.
Repeated Administration of MDMA Increases Huddling in a Subject with Initially Low MDMA-Induced Social Behaviors
One animal (177) in the group of four squirrel monkeys initially showed low levels of group huddling following MDMA administration (Figure 1b) . However, following repeated, acute administration of racemic MDMA and its enantiomers over the course of the study, 177 developed similar levels of huddling as the other three subjects. There was a significant three-way interaction between phase, dose, and subject (F 3, 208 = 3.39, p = 0.019) and comparing the least-squares means between phases within each subject showed a significant increase in the average time spent huddling by 177 between phases (phase 1: 35.8 ± 32.8 s; phase 2: 202.1 ± 44.1 s; t 208 = 3.64, p = 0.002) but not the other three animals (Supplementary Figure S3) . This is not a systematic study of the long-term effects of MDMA, but it is interesting given the long-term effects of MDMA in clinical settings (Mithoefer et al, 2013) . Future studies could examine the potential long-term social and group effects of MDMA in a more controlled manner.
DISCUSSION
The aim of the present study was to examine the affiliative social effects of MDMA in socially housed squirrel monkeys and to examine the 5-HT receptor pharmacology underlying MDMA-induced social behaviors. MDMA and its enantiomers dose-dependently increased huddling and the number of affiliative vocalizations emitted by group-housed squirrel monkeys. Additionally, pretreatments with a 5-HT 2A receptor antagonist or a 5-HT 2C receptor agonist attenuated MDMA-induced huddling and a 5-HT 1A receptor antagonist increased MDMA-induced huddling but did not change affiliative vocalizations. Studies have shown that MDMA increases feelings of sociability in humans and increases social interaction in rodents (Kamilar-Britt and Bedi, 2015) . The only study to examine the social effects of MDMA in nonhuman primates also found that MDMA increases social grooming in longtailed macaques (Ballesta et al, 2016) . In concordance with this research, the present experiments found that MDMA significantly increases huddling and affiliative calls in squirrel monkeys.
MDMA also increased growl calls, vocalizations usually connected with aggression (Jurgens, 1979) . This was unexpected given that MDMA decreases aggression in other animal models (Kamilar-Britt and Bedi, 2015) . No aggressive behaviors or other aggressive calls were seen and growl calls, when they occur with chucks, have been seen during huddling (Winter, 1968) . This suggests that growls are not exclusively aggressive and may not be indicating aggression in this context, although further studies are necessary.
In contrast with the behavioral changes following MDMA administration, methamphetamine did not significantly increase huddling or affiliative vocalizations. These findings support the unique, robust social effects of MDMA and the use of group-housed squirrel monkeys to further examine those social effects and the underlying mechanisms of MDMA. One limitation of our study was that vocalizations were examined by group, making it impossible to determine if all subjects drove the increase in affiliative vocalizations equally. Future studies could separate calls by subject in order to examine individual differences in MDMA-induced vocalizations. The effects of MDMA in female and juvenile group-housed squirrel monkeys should also be examined to determine whether sex and age have a role in MDMAinduced social behaviors.
Interestingly, despite its structural similarity to psychostimulant compounds, MDMA significantly decreased activity in nonhuman primates. This finding supports other studies showing decreased activity levels following MDMA (Crean et al, 2006) and no stimulant effects on operant behavior (Fantegrossi et al, 2009 ). The present study's group-housing design might enhance changes in activity levels as animals switch allocation of behavior from non-social activity toward affiliative social behaviors. Another interpretation, however, could be that increases in huddling are driven by decreases in locomotion. Previous research supports the conclusion that huddling is independent of locomotor effects following drug administration. Drugs that decrease locomotion do not reliably increase huddling (Miczek et al, 1981) and the effects of stimulants on locomotion and social behaviors are not mediated by the same mechanisms (Miczek and Yoshimura, 1982) . This is further supported by our findings showing dissociation between the effects of 5-HT receptor ligands on MDMA-induced huddling and locomotion.
In the present study, pretreatment with M100, a selective 5-HT 2A receptor antagonist, blocked MDMA-induced affiliative social behaviors. Antagonism of 5-HT 2A receptors blocks MDMA-induced striatal dopamine overflow (Schmidt et al, 1994) . A potential role of 5-HT-mediated striatal dopamine release in the social effects of MDMA is supported by results indicating that pretreatment with WAY163, a 5-HT 2C receptor agonist, also decreases MDMA-induced huddling, because 5-HT 2C receptor activation decreases striatal dopamine release (Howell and Cunningham, 2015) . Additionally, the 5-HT 2A receptor is expressed extensively throughout the amygdala (Bombardi and Di Giovanni, 2013) and reduces amygdala-dependent reactivity and anxietyrelated behaviors (Weisstaub et al, 2006; Fisher et al, 2009 ). Given the model that MDMA produces a valence-specific shift in response to social cues, with an increase in recognition of positive social signals and a decrease in response and recognition of negative ones (Kamilar-Britt and Bedi, 2015) , the striatal and amygdalar effects of 5-HT 2A receptor activation provide a potential mechanism by which 5-HT 2A receptors could mediate increased sociality following MDMA.
One potential caveat with the present study is that MDMA has pronounced effects on body temperature (eg, Banks et al, 2007) and antagonism of the 5-HT 2A receptor attenuates MDMA-induced changes in body temperature in rodents (Herin et al, 2005) and humans (Liechti et al, 2000b) . The temperature of the laboratory (near an ambient temperature in which MDMA administration did not change body temperature in nonhuman primates; Banks et al, 2007) and correlation between affiliative vocalizations and huddling following MDMA (Supplementary Figure S4A) suggest the findings are not driven by changes in body temperature. Additionally, methamphetamine stimulates even more pronounced changes in body temperature (Crean et al, 2006) but did not induce a similar increase in huddling.
The 5-HT 1A receptor is also thought to have a role in the social effects of MDMA. In rodents, 5-HT 1A receptor stimulation is necessary for MDMA-induced increases in adjacent lying and oxytocin release (Thompson et al, 2007) and activation of oxytocin neurons (Hunt et al, 2011) . Further, one study showed positive correlation between plasma oxytocin and social ratings in the laboratory (Dumont et al, 2009 ). Counter to these findings, pretreatment with WAY100, a selective 5-HT 1A receptor antagonist, increased huddling following MDMA administration and did not affect MDMA-induced vocalizations. Future studies using a wider range of doses of WAY100 and/or 5-HT 1A agonists could provide more definitive evidence on the role of the 5-HT 1A receptor in social behaviors.
The present study supports evidence in the human literature showing that blocking 5-HT 1A receptors does not change increases in self-reported ratings of sociality or emotional empathy following MDMA (van Wel et al, 2012; Kuypers et al, 2014) and null correlations between plasma oxytocin and social feelings (eg, Kuypers et al, 2014) . The enhancement of MDMA-induced huddling could have been driven by antagonism of 5-HT 1A autoreceptors, driving an additional increase in 5-HT release. 5-HT 1A receptor antagonism potentiates 5-HT release following administration of selective serotonin reuptake inhibitors (SSRIs) (Hjorth, 1993) . Administration of an SSRI increases body contact and grooming behaviors in cynomolgous macaques (Shively et al, 2014) , indicating that 5-HT release alone can increase social contact in nonhuman primates. However, further studies are needed to confirm that 5-HT 1A receptor antagonism is enhancing MDMA-induced huddling by blunting autoreceptor feedback.
We propose a model for the unique social effects of MDMA, in which 5-HT release, combined with receptorselective direct agonist effects, enhances sociality. In this model, 5-HT release alone can enhance some social behaviors (as seen with increased body contact following SSRI administration; Shively et al, 2014) , but the addition of receptor-selective activation enhances these social effects, leading to the unique and robust social behavior caused by MDMA. This model is supported by the dissociation between huddling and affiliative vocalizations following 5-HT 1A receptor antagonism, with additional 5-HT release increasing huddling but not affecting affiliative vocalizations. The differing magnitude of effects of the MDMA enantiomers also provides support for the above model. The S(+) enantiomer is a potent releaser of 5-HT and dopamine, while the R( − ) enantiomer releases less 5-HT and is ineffective in releasing dopamine (Acquas et al, 2007; Murnane et al, 2010) but binds to the 5-HT 2 receptor (Lyon et al, 1986) . S(+) increases huddling more strongly than R( − ) at the same dose, as expected given its more potent release of 5-HT. However, in contrast with its more potent monoamine releasing effects, S(+) is less effective at eliciting affiliative vocalizations at higher doses than R( − ). Accordingly, the enhanced social effects of R( − ) MDMA are possibly caused by the combination of 5-HT release and receptor-selective direct agonism. Future studies could examine this model more directly by co-administering S(+) MDMA or a 5-HT releaser with 5-HT receptor agonists (eg, DOI) and by further studying the role of agonism at other receptor types, such as adrenergic or dopaminergic receptors, in the effects of both enantiomers.
MDMA is currently being evaluated as a therapeutic adjunct for the treatment of PTSD (Mithoefer et al, 2011 (Mithoefer et al, , 2013 . MDMA-assisted psychotherapy sessions may produce long-term decreases in PTSD symptoms in treatmentresistant patients (Mithoefer et al, 2013 ). An increase in therapeutic alliance from increased sociality and openness following MDMA is thought to have a role in the therapeutic potential of MDMA (Mithoefer et al, 2011) . However, there are still concerns about the potential neurotoxicity and abuse potential that limit its clinical appeal (Rietjens et al, 2012) . Understanding the neuropharmacological mechanisms of the prosocial effects of MDMA could allow for the development of novel therapeutics that specifically target social behavior, while limiting abuse potential, toxicity, and other side effects, which may be especially advantageous in vulnerable clinical populations. The evidence that R( − ) MDMA increases social behaviors to a level similar to racemic MDMA, without causing large amounts of striatal dopamine release (Acquas et al, 2007; Murnane et al, 2010) or inducing neurotoxic effects (Frau et al, 2013) , provides a rationale for its potential advantage in therapeutic settings.
FUNDING AND DISCLOSURE
